84 related articles for article (PubMed ID: 12023746)
1. [Efficacy of latanoprost monotherapy treatment in primary open-angle glaucoma].
Martínez García A; Pérez García R
Arch Soc Esp Oftalmol; 2002 May; 77(5):269-74. PubMed ID: 12023746
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of latanoprost for the treatment of pediatric glaucoma.
Enyedi LB; Freedman SF; Buckley EG
J AAPOS; 1999 Feb; 3(1):33-9. PubMed ID: 10071899
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of latanoprost additive therapy on uncontrolled glaucoma.
Bayer A; Tas A; Sobaci G; Henderer JD
Ophthalmologica; 2002; 216(6):443-8. PubMed ID: 12566890
[TBL] [Abstract][Full Text] [Related]
4. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
[TBL] [Abstract][Full Text] [Related]
5. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
Maruyama K; Shirato S
J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
[TBL] [Abstract][Full Text] [Related]
7. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
8. Effect of latanoprost on intraocular pressure in steroid-induced glaucoma.
Scherer WJ; Hauber FA
J Glaucoma; 2000 Apr; 9(2):179-82. PubMed ID: 10782629
[TBL] [Abstract][Full Text] [Related]
9. Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial.
Mansouri K; Orguel S; Mermoud A; Haefliger I; Flammer J; Ravinet E; Shaarawy T
Br J Ophthalmol; 2008 Mar; 92(3):332-6. PubMed ID: 18211927
[TBL] [Abstract][Full Text] [Related]
10. Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma.
Aspberg J; Heijl A; Jóhannesson G; Lindén C; Andersson-Geimer S; Bengtsson B
J Glaucoma; 2018 Nov; 27(11):976-980. PubMed ID: 30113517
[TBL] [Abstract][Full Text] [Related]
11. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
12. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
Hatanaka M; Reis A; Sano ME; Susanna R
J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
[TBL] [Abstract][Full Text] [Related]
13. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the intraocular pressure-reducing effect of latanoprost as monotherapy in open-angle glaucoma.
Mandić Z; Bojić L; Novak-Laus K; Sarić D
Coll Antropol; 2002 Dec; 26(2):595-600. PubMed ID: 12528287
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.
Chiseliţă D; Antohi I; Medvichi R; Danielescu C
Oftalmologia; 2005; 49(3):39-45. PubMed ID: 16408674
[TBL] [Abstract][Full Text] [Related]
16. A retrospective review of non-responders to latanoprost.
Scherer WJ
J Ocul Pharmacol Ther; 2002 Jun; 18(3):287-91. PubMed ID: 12099549
[TBL] [Abstract][Full Text] [Related]
17. Additional reduction in intraocular pressure achieved with latanoprost in normal-tension glaucoma patients previously treated with unoprostone.
Enoki M; Saito J; Hara M; Uchida T; Sagara T; Nishida T
Jpn J Ophthalmol; 2006; 50(4):334-337. PubMed ID: 16897217
[TBL] [Abstract][Full Text] [Related]
18. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.
Simmons ST; Bernstein P; Hollander DA
Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893
[TBL] [Abstract][Full Text] [Related]
19. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
Gandolfi SA; Cimino L
Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
[TBL] [Abstract][Full Text] [Related]
20. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
